Home » Topics » BioWorld Science

BioWorld Science
RSS

Lack of genomic diversity means actionable mutations are left undiscovered

Dec. 31, 2019

AC Immune patents alpha-synuclein-targeting compounds for PET imaging

Dec. 31, 2019

Phase II data presented for efgartigimod in adults with primary ITP

Dec. 31, 2019

Promising preclinical data presented for the HER2-targeting engineered toxin body MT-5111

Dec. 31, 2019

Long-term follow-up data presented from phase IIa study of KD-025 in cGvHD

Dec. 31, 2019

Bacterial peptides can be gluten lookalikes

Dec. 31, 2019

Novel TRIM24(COE) mouse model of metaplastic TNBC

Dec. 31, 2019

UNC-0638 in combination with HRI knockdown leads to induction of fetal hemoglobin

Dec. 31, 2019

CTI BioPharma presents data from dose-finding PAC203 study of pacritinib

Dec. 31, 2019

Eli Lilly initiates phase III trial with selpercatinib in RET-mutant medullary thyroid cancer

Dec. 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...